Federation of African Pharmaceutical Manufacturers Associations to be launched

22 January 2013

In an effort to further develop and strengthen local production of pharmaceutical produce in Africa, three African regional associations of African Pharmaceutical Manufacturers have come together to establish the Federation of African Pharmaceutical Manufacturers Associations (FAPMA), which will ultimately form an umbrella organization representing the pharmaceutical manufacturing sector in Africa.

The launch of the FAPMA will take place on January 25 at the Harmony Hotel in Addis Ababa, Ethiopia. Founding members include the three main African regional associations: the West African Pharmaceutical Manufacturers Association (WAPMA), the Federation of East African Pharmaceutical Manufacturers Associations (FEAPM) and the Southern African Generic Medicines Association (SAGMA).

At the occasion of the launch, two key note addresses will be followed by panel discussions on strengthening local production in Africa. The first panel will debate the private sector’s response to the challenges and opportunities facing Africa’s pharmaceutical industry while the second panel will shed light on how the private sector could, and should organize itself to respond to the challenges and opportunities.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics